| S8859 |
BMS-1166 |
BMS-1166 is a novel and potent small molecule inhibitor of the PD-1/PD-L1 interaction with an IC50 of 1.4 nM. |
Selective |
PD-1/PD-L1 interaction, IC50: 1.4 nM |
| S8158 |
PD-1/PD-L1 Inhibitor 3 |
PD-1/PD-L1 Inhibitor 3(Programmed Death-1/Programmed Death-Ligand 1 Inhibitor 3)is a Macrocyclic inhibitor of PD-1/PD-L1 interaction with IC50 of 5.6 nM |
Selective |
PD-1/PD-L1 interaction, IC50: 5.6 nM |
| S7911 |
BMS-1 |
BMS-1 is a small-molecule inhibitor of PD-1/PD-L1 interaction with IC50 of 6 nM. |
Selective |
PD-1/PD-L1 interaction, IC50: 0.006 μM |
| S9863 |
INCB086550 |
INCB086550 (PD-1/PD-L1-IN-8) is a potent PD-1/PD-L1 inhibitor, with an IC50 <= 10 nM. |
Selective |
PD-1/PD-L1, IC50: <10 nM |
| S7912 |
BMS202 |
BMS202 is a small-molecule PD-1/PD-L1 interaction inhibitor with IC50 of 18 nM.
|
Selective |
PD-1/PD-L1 interaction, IC50: 0.018 μM |
| S9610 |
BMS-1001 |
BMS-1001 is a potent inhibitor of PD-1/PD-L1 interaction with EC50 of 253 nM. BMS-1001 alleviates the inhibitory effect of the soluble PD-L1 on the T-cell receptor-mediated activation of T-lymphocytes. |
Selective |
PD-1/PD-L1, EC50: 253 nM |